Trial intelligence / Profile preview

Atumelnant in ACTH-dependent Cushing's syndrome

ACTRN12626000211369Phase 2Not yet recruiting

Sponsor

Crinetics Pharmaceuticals

Start

Jul 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

14